Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Former Edgewise and Merck leader brings more than 15 years’ experience to guide Immutrin’s clinical strategy as the Company advances towards first-in-human studies Cambridge, UK, 6th May 2026Immutrin...
-
Former Edgewise and Merck leader brings more than 15 years’ experience to guide Immutrin’s clinical strategy as the Company advances towards first-in-human studies Cambridge, UK, 6th May 2026Immutrin...
-
LaFleur Minerals Strengthens Leadership with Former Probe Gold and Probe Mines Executives to Accelerate Exploration Growth and Beacon Gold Mill Restart
-
LOS ALTOS, Calif., May 05, 2026 (GLOBE NEWSWIRE) -- Fast Simon has named Shaun Lin as director of partnerships, tasking him with expanding the company's agency and technology partner network across...
-
SINGAPORE, May 05, 2026 (GLOBE NEWSWIRE) -- HomesToLife Ltd (Nasdaq: HTLM) (“HomesToLife” or the “Company”) today announced that its Board of Directors has appointed Mr. Zhengjie “Jeff” Chai (“Mr....
-
Fancamp Exploration appoints Blake Rhodes (ex-Newmont) to its Board of Directors, seasoned mining executive with more than 25 years of global experience.
-
PRESS RELEASE — APRIL 30, 2026 Sébastien Metzger appointed General Counsel of Wendel Wendel announces the appointment of Sébastien Metzger as General Counsel of Wendel. He succeeds Caroline...
-
COMMUNIQUÉ — 30.04.2026 Sébastien Metzger nommé Secrétaire général de Wendel Wendel annonce la nomination de Sébastien Metzger en tant que Secrétaire général de Wendel. Il succède à Caroline...
-
Ad-hoc-Mitteilung gemäss Art. 53 KR. Dario Eklund übergibt die leitung nach geplanter übergangsphase Pratteln, Schweiz, 23. April 2026 – Santhera Pharmaceuticals (SIX: SANN) gibt die Ernennung von...
-
Ad hoc announcement pursuant to Art. 53 LR. Dario Eklund to hand over leadership following planned transition Pratteln, Switzerland, April 23, 2026 – Santhera Pharmaceuticals (SIX: SANN) announces...